16:42 , Apr 5, 2018 |  BC Innovations  |  Finance

Public funding highlights

Public funding highlights Selected developments and initiatives in 1Q18 from major sources of public funding including National Institutes of Health (NIH), the U.K.’s Medical Research Council (MRC), the Innovative Medicines Initiative (IMI), the Canadian Institutes...
07:00 , Jul 20, 2015 |  BC Week In Review  |  Company News

biOasis, National Research Council Canada, Universite de Sherbrooke deal

biOasis partnered with the National Research Council of Canada and the Universite de Sherbrooke to identify blood-brain barrier (BBB) carrier molecules for use with neurotherapeutics. The partners have been awarded C$2.6 million ($2 million) in...
07:00 , Sep 11, 2014 |  BC Innovations  |  Strategy

Buckets of money for the brain

Apart from the recent ALS ice-bucket challenge, the perception is that neurological disorders have become the poor relation of oncology and other diseases when it comes to public and private funding. But an uptick in...
07:00 , Jun 12, 2014 |  BC Innovations  |  Strategy

CQDM: Canada on the brain

The Quebec Consortium for Drug Discovery and Brain Canada have announced at least C$10 million (US$9.2 million) in funding for a new program to develop tools to accelerate the discovery of neurological disease therapies. Under...